Faster to Clinic Approach and the impact of ICH Q14 & ICH Q2(R2) on phase-appropriate drug development.
Time: 12:30 pm
day: Day One
Details:
- Understanding ICH Q14/Q2(R2): This presentation will cover the new ICH Q14 and ICH Q2(R2) guidelines, focusing on their impact on each phase of drug development.
- Phase-Specific Strategies: We'll explore strategies tailored to each development phase, aligning with ICH Q14/Q2(R2) requirements.
- Correlation with New Guidelines: The talk will also highlight how the data requirements for each phase relate to the new ICH guidelines, ensuring compliance and efficiency.
